API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/alliancerx-walgreens-prime-relaunches-exclusive-partnership-for-the-distribution-of-cystaran-cysteamine-ophthalmic-solution-0-44-301506976.html
https://www.benzinga.com/general/biotech/22/02/25512694/after-fabry-trial-setback-avrobio-hopes-rebound-with-lysosomal-storage-disorder-data
https://www.biospace.com/article/releases/recordati-rare-diseases-announces-availability-of-cystadrops-cysteamine-ophthalmic-solution-0-37-percent-in-the-u-s-/
https://www.reuters.com/article/us-recordati-canada/recordati-to-seek-canadian-approval-for-kidney-disease-drug-idUSKCN1RS1YP?feedType=RSS&feedName=healthNews